OneOme Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$6.4M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • OneOme's estimated annual revenue is currently $19.1M per year.(?)
  • OneOme's estimated revenue per employee is $155,000
  • OneOme's total funding is $6.4M.

Employee Data

  • OneOme has 123 Employees.(?)
  • OneOme currently has 1 job openings.

At OneOme, we deliver outstanding individualized medicine through a targeted, high-quality pharmacogenomic test combined with clinical decision support co-developed and exclusively licensed from Mayo Clinic. We work closely with Mayo Clinic to enhance existing pharmacogenomic testing by ensuring our comprehensive test is ordered by a healthcare provider and by providing highly actionable pharmacogenomic results across many areas of medicine. The OneOme RightMed pharmacogenomic test integrates a patient’s genetic profile, current prescriptions, and drug-drug interactions and processes this information using a proprietary algorithm-based platform—developed with years of pharmacogenomics expertise and curated clinical data—to provide a dynamic, actionable report. We continue to develop, improve, and update our algorithms and database of clinical information, enabling healthcare providers to treat each patient uniquely based on their pharmacogenomic results. Now you have the potential to make a prescription the right one, the first time.